Inventor · disambiguated record
Suganthini S. Nanthakumar
Also filed as: NANTHAKUMAR SUGANTHINI · NANTHAKUMAR SUGANTHINI S
16 granted patents·6 pending applications·470 citations·filing 2002–2024
94Inventor score
Top patents by PatentIndex Score
22 records- 0197US6949544B2Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinasesVERTEX PHARMA·Filed 2002·Granted Sep 27, 2005·151 cites·25 claims
- 0297US6762179B2Thiazole compounds useful as inhibitors of protein kinaseVERTEX PHARMA·Filed 2002·Granted Jul 13, 2004·111 cites·11 claims
- 0395US7488727B2Thiazole compounds useful as inhibitors of protein kinaseVERTEX PHARMA·Filed 2007·Granted Feb 10, 2009·41 cites·11 claims
- 0494US7514448B2Azaindoles useful as inhibitors of rock and other protein kinasesVERTEX PHARMA·Filed 2005·Granted Apr 7, 2009·36 cites·17 claims
- 0593US8466288B2Isoindolinone inhibitors of phosphatidylinositol 3-kinaseARONOV ALEX·Filed 2012·Granted Jun 18, 2013·38 cites·18 claims
- 0692US11866446B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Jan 9, 2024·7 cites·55 claims
- 0791US12060346B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2023·Granted Aug 13, 2024·1 cites·53 claims
- 0891US11618746B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2019·Granted Apr 4, 2023·6 cites·28 claims
- 0989US7256190B2Thiazole compounds useful as inhibitors of protein kinaseVERTEX PHARMA·Filed 2004·Granted Aug 14, 2007·33 cites·8 claims
- 1088US9676759B2Isoindolinone inhibitors of phosphatidylinositol 3-kinaseVERTEX PHARMA·Filed 2013·Granted Jun 13, 2017·8 cites·11 claims
- 1188US7304071B2Protein kinase inhibitors and uses thereofVERTEX PHARMA·Filed 2003·Granted Dec 4, 2007·35 cites·20 claims
- 1282US12281102B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Apr 22, 2025·1 cites·38 claims
- 1382US12116343B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Oct 15, 2024·1 cites·33 claims
- 1478US2025042878A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1576US10183933B2Isoindolinone inhibitors of phosphatidylinositol 3-kinaseVERTEX PHARMA·Filed 2017·Granted Jan 22, 2019·1 cites·10 claims
- 1671US12421249B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2023·Granted Sep 23, 2025·0 cites·23 claims
- 1760US2025136612A14',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1853US2023014907A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1952US2012040950A1Isoindolinone inhibitors of phosphatidylinositol 3-kinaseARONOV ALEX·Filed 2010·Application pending·0 cites
- 2043US2014065103A1Compounds and methods for the treatment or prevention of flaviviridae viral infectionsVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2140US8481538B2Heterocyclic inhibitors of c-Met and uses thereofARONOV ALEXANDER·Filed 2007·Granted Jul 9, 2013·0 cites·13 claims
- 2239US2018251431A11,3-substituted pyrazole compounds useful for reduction of very long chain fatty acid levelsVERTEX PHARMA·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Suganthini S. Nanthakumar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →